Edited by Peter Hillerberg1 min readStories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
Suspected pneumonic plague in Russia jolted options markets overnight. Moderna, Novavax, and Vaxcyte all trended after-hours as traders rushed to price in an unexpected outbreak scenario.
NVAX carries an ORTEX short score of 80.9. Days to cover stand at 10.8. That combination of high short interest and a sudden catalyst makes it a prime target for rapid call buying. PCVX shows 9.1 days to cover, with analysts pricing in 92% upside to their target price.
The move comes alongside a record US jobs backdrop. Nonfarm payrolls hit 159,044 thousand in September 2026, the largest September reading since 1997, per ORTEX Alt Data. Average hourly earnings reached $37.81, also a record for September. Strong labour data typically favours equity bulls and underpins broader call sentiment.
Cybersecurity names also drew options attention. Zscaler reports results today. Analysts have been raising targets. The stock is down 13% year-to-date but carries 6.9% analyst upside. Elevated pre-earnings options volume in cybersecurity peers PANW and CRWD suggests the sector is in focus.
Across large-cap names, options positive flow hit 100% on several transport and industrials stocks, including Union Pacific, CSX, and Norfolk Southern. That sweep of bullish rails sentiment aligns with a strong freight and labour picture. Medicare Advantage penetration reaching 51.1% in June 2026, its sixth straight monthly rise, also adds a tailwind to healthcare options flow.
The single clearest signal of the session: biotech calls. The plague headline drove an unusual spike in a sector that rarely moves this fast on geopolitical news.
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
